Healthcare
Eli Lilly and Company (LLY)
Eli Lilly and Company stock analysis and opportunity scoring
$1174.61
↓ -0.13%
Eli Lilly and Company (LLY) at a glance
Eli Lilly and Company (LLY) is a publicly traded company in the Healthcare - Drug Manufacturers - General sector tracked by MKD Intelligence.
LLY last traded at $1148.84 as of 2026-08-29.
MKD Intelligence assigns LLY a composite opportunity score of 40 out of 100, indicating cautious conditions across trend, momentum and volume factors.
The risk score for LLY is 47 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$1280.34
Low
$1115.68
Period
Aug 28 - Jul 31 (21d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
Reuters · 2d ago
Eli Lilly's diabetes drug Mounjaro gets approval for a new use - USA Today
USA Today · 2d ago
Upcoming Events
Data as of Aug 29
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.